medvi semaglutide reviews consumer reports MEDVi, founded by Matthew Gallagher, is a telehealth platform selling GLP-1 weight-loss drugs directly to consumers and was built in about 2 months with roughly $20K. It is now tracking toward $1.8B Best Semaglutide Options for 2026:
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2




&srotate=0)























